The Over-Expression of Prion Protein Associated with Loss of SMAD4 in Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Zhang, L.
Xin, W.
机构：
[1] Nanjing Gulou Hosp, Jiangsu, Peoples R China
[2] Univ Hosp Geneva, Case Med Ctr, Cleveland, OH USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1479
引用
收藏
页码：326A / 326A
页数：1
相关论文
共 50 条
  • [1] The Over-Expression of Prion Protein Associated with Loss of SMAD4 in Pancreatic Ductal Adenocarcinoma
    Zhang, L.
    Xin, W.
    MODERN PATHOLOGY, 2009, 22 : 326A - 326A
  • [2] The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma
    Tascilar, M
    Skinner, HG
    Rosty, C
    Sohn, T
    Wilentz, RE
    Offerhaus, GJA
    Adsay, V
    Abrams, RA
    Cameron, JL
    Kern, SE
    Yeo, CJ
    Hruban, RH
    Goggins, M
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4115 - 4121
  • [3] DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma
    Biankin, AV
    Morey, AL
    Lee, CS
    Kench, JG
    Biankin, SA
    Hook, HC
    Head, DR
    Hugh, TB
    Sutherland, RL
    Henshall, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) : 4531 - 4542
  • [4] SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
    Yu-Wen Chen
    Pi-Jung Hsiao
    Ching-Chieh Weng
    Kung-Kai Kuo
    Tzu-Lei Kuo
    Deng-Chyang Wu
    Wen-Chun Hung
    Kuang-Hung Cheng
    BMC Cancer, 14
  • [5] SMAD4 Loss is a Predictor of Neoadjuvant Treatment Response in Pancreatic Ductal Adenocarcinoma
    Ramanathan, R.
    Hodges, J.
    Al-Abbas, A.
    Buchholz, C.
    Singhi, A.
    Zeh, H.
    Hogg, M. E.
    Zureikat, A. H.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S34 - S34
  • [6] SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
    Chen, Yu-Wen
    Hsiao, Pi-Jung
    Weng, Ching-Chieh
    Kuo, Kung-Kai
    Kuo, Tzu-Lei
    Wu, Deng-Chyang
    Hung, Wen-Chun
    Cheng, Kuang-Hung
    BMC CANCER, 2014, 14
  • [7] SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
    Dardare, Julie
    Witz, Andrea
    Merlin, Jean-Louis
    Gilson, Pauline
    Harle, Alexandre
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [8] Smad4 is Associated With Differentiation of Pancreatic Ductal Adenocarcinomas
    Izumi, S.
    Ichihara, S.
    Kubo, T.
    Ohtani, H.
    Yano, M.
    Tanaka, N.
    Ohashi, R.
    Onoda, Y.
    Suzuka, I.
    PANCREAS, 2014, 43 (08) : 1369 - 1369
  • [9] Impact of SMAD4 loss in patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy.
    Racu, Marie-Lucie
    Bernardi, Dana
    Chaouche, Aniss
    Zindy, Egor
    Navez, Julie
    Loi, Patrizia
    Maris, Calliope
    Closset, Jean
    Van Laethem, Jean-Luc
    Decaestecker, Christine
    Salmon, Isabelle
    D'Haene, Nicky
    CANCER RESEARCH, 2022, 82 (22) : 86 - 86
  • [10] A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma
    Singh, P.
    Wig, J. D.
    Srinivasan, R.
    Radotra, B. D.
    INDIAN JOURNAL OF CANCER, 2011, 48 (02) : 170 - 174
12345